< prev         [menu]         next >

                                                    
                                                     GENE THERAPIES

In 2003 the British Food and Drug Administration eased the ban on gene therapy trials using retroviral vectors in blood stem cells.

The cost of decoding a person's genome is likely to fall from $50,000 now to $100 by 2015.

One in four people carry a set of genes that increases our risk of heart disease by 40%.